Insider · CIK 0001662930
Niraj Vasisht
Files at INTI (Inhibitor Therapeutics, Inc.). First filing -, latest -.
In brief
Niraj Vasisht files SEC Form 4 as director at INTI (Inhibitor Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Niraj Vasisht has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | INTI Inhibitor Therapeutics, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 200,000 | Jun 1, 2026 |
| Apr 1, 2025 | INTI Inhibitor Therapeutics, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | - | Apr 10, 2025 |
Questions about Niraj Vasisht
Answered from the filings on this page, as of the latest one.
Is Niraj Vasisht buying or selling?
Niraj Vasisht has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Niraj Vasisht's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Niraj Vasisht has 0.
Where does Niraj Vasisht file Form 4?
Niraj Vasisht has filed Form 4 at INTI (Inhibitor Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.